Anzeige
Mehr »
Sonntag, 05.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CUMB | ISIN: IT0005452658 | Ticker-Symbol: 87N
Frankfurt
03.10.25 | 19:55
22,200 Euro
-1,77 % -0,400
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
STEVANATO GROUP SPA Chart 1 Jahr
5-Tage-Chart
STEVANATO GROUP SPA 5-Tage-Chart
RealtimeGeldBriefZeit
21,80022,40004.10.
21,80022,40003.10.

Aktuelle News zur STEVANATO GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.09.Stevanato Group SpA (STVN) Share Gained 20% as Results Exceeded Expectations4
03.09.Stevanato Group S.p.A.: Stevanato Group to Participate in Upcoming Investor Conferences255Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
► Artikel lesen
25.08.Here's Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN)1
12.08.Stevanato Group S.p.A. - 6-K, Report of foreign issuer4
05.08.Stevanato Group S.p.A. - 6-K, Report of foreign issuer1
05.08.Stevanato Group S.p.A.: Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025480Company delivers 8% revenue growth, expanded margins, and maintains fiscal year 2025 guidance Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery...
► Artikel lesen
STEVANATO GROUP Aktie jetzt für 0€ handeln
23.07.Stevanato Group Secures $235.4 Million in Financing1
23.07.Stevanato secures €200 million financing for global expansion1
23.07.Stevanato secures €200M in financing1
23.07.Stevanato Group S.p.A.: Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.716Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
22.07.Stevanato Group S.p.A.: Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025329Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
05.06.Stevanato Group auf Jefferies-Konferenz: Strategisches Wachstum und Expansion1
13.05.Stevanato Group S.p.A. - 6-K, Report of foreign issuer2
09.05.Stevanato Group S.p.A.: Stevanato Group to Participate in Upcoming Investor Conferences310Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
► Artikel lesen
08.05.Stevanato Group Non-GAAP EPS of €0.10 in-line, revenue of €256.6M misses by €23.36M5
08.05.Stevanato Group S.p.A.: Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025389Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
► Artikel lesen
05.05.Stevanato Group declares $0.0613 dividend3
02.05.Stevanato Group S.p.A. - 6-K, Report of foreign issuer1
24.04.Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025363Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
11.03.Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum295Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
► Artikel lesen
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1